Table 2.
Cell count (CFU)/ml | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LAVRI-A1 | LGG | Bl536 | B94 | St1275 | E. coli | |||||||
Treatment | 0 h | 18 h | 0 h | 18 h | 0 h | 18 h | 0 h | 18 h | 0 h | 18 h | 0 h | 18 h |
Live | 7·47 | 9·06 | 7·00 | 9·29 | 7·31 | 8·74 | 7·10 | 8·65 | 7·10 | 8·77 | 6·89 | 8·56 |
GIT simulation | 6·27 | 8·12 | 6·00 | 8·43 | 6·10 | 8·53 | 6·15 | 8·39 | 6·00 | 8·02 | 6·00 | 8·27 |
Killed | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
s.e.m. | 0·24 |
Results presented as a mean (n = 3) ± pooled standard error of the mean (s.e.m.) (0·243). Lactobacillus (Lb.) acidophilus LAVRI-A1; Lb. rhamnosus GG (LGG); Bifidobacterium (B.) lactis B94; B. longum BL536; exopolysaccharides (EPS)-producing Streptococcus (S.) thermophilus St1275; Escherichia (E.) coli; GIT: gastrointestinal tract; CFU: colony-forming units.